Health Care [ 3/12 ] | Biotechnology [ 26/73 ]
NASDAQ | Common Stock
ImmunoPrecise Antibodies Ltd. operates as an AI-driven biotherapeutic research, technology, and scientifically robust life science company.
It discovers and develops customized and novel antibodies by generating proprietary and patented processes, procedures, and innovative approaches to antibody discovery, development, and production.
The company was incorporated in 1983 and is headquartered in Austin, Texas.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Jul 28, 25 | -0.04 Increased by +66.82% | -0.04 Decreased by -4.29% |
| Mar 12, 25 | -0.46 Decreased by -319.91% | -0.06 Decreased by -724.82% |
| Dec 12, 24 | -0.06 Increased by +36.30% | -0.07 Increased by +9.00% |
| Sep 16, 24 | -0.11 Increased by +21.43% | -0.08 Decreased by -37.50% |
| Jul 29, 24 | -0.11 Increased by +47.62% | -0.11 |
| Mar 14, 24 | -0.11 Increased by +42.11% | -0.10 Decreased by -10.00% |
| Dec 14, 23 | -0.10 Increased by +66.67% | -0.13 Increased by +23.08% |
| Sep 14, 23 | -0.14 Increased by +63.16% | -0.20 Increased by +30.00% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Apr 30, 25 | 6.98 M Increased by +8.08% | -2.16 M Increased by +88.02% | Decreased by -30.96% Increased by +88.92% |
| Jan 31, 25 | 6.15 M Decreased by -1.13% | -21.52 M Decreased by -703.32% | Decreased by -349.88% Decreased by -712.46% |
| Oct 31, 24 | 6.13 M Decreased by -0.41% | -2.55 M Increased by +2.63% | Decreased by -41.68% Increased by +2.23% |
| Jul 31, 24 | 5.26 M Decreased by -7.47% | -4.00 M Decreased by -17.07% | Decreased by -75.98% Decreased by -26.52% |
| Apr 30, 24 | 6.46 M Increased by +14.91% | -18.05 M Decreased by -251.82% | Decreased by -279.38% Decreased by -206.18% |
| Jan 31, 24 | 6.22 M Increased by +20.31% | -2.68 M Increased by +42.99% | Decreased by -43.06% Increased by +52.61% |
| Oct 31, 23 | 6.15 M Increased by +18.63% | -2.62 M Increased by +64.33% | Decreased by -42.63% Increased by +69.93% |
| Jul 31, 23 | 5.69 M Increased by +21.31% | -3.42 M Increased by +63.59% | Decreased by -60.06% Increased by +69.98% |